Question

When administering diphenoxylate and atropine (Lomotil) to a client with ulcerative colitis, the nurse should monitor the client for the development of?

Answer 1

When administering diphenoxylate with atropine for ulcerative colitis, a nurse should monitor for the development of intestinal obstruction, anticholinergic side effects, and central nervous system effects.

Step-by-step explanation:

When administering diphenoxylate and atropine (Lomotil) to a client with ulcerative colitis, a nurse should monitor for several potential side effects, but particularly for the development of intestinal obstruction. Diphenoxylate is an antidiarrheal medication that works by slowing the movement of the intestines. While this can be beneficial in controlling diarrhea associated with ulcerative colitis, it can also lead to an increased risk of an intestinal blockage or obstruction, especially if the intestinal movement slows too much.

Additionally, the atropine in Lomotil, which is included to discourage abuse of diphenoxylate, can cause anticholinergic side effects such as dry mouth, blurred vision, and urinary retention. Patients should also be assessed for signs of central nervous system effects, including confusion or drowsiness, which could impact their ability to participate in their care or perform daily activities safely. Monitoring for these symptoms is important because they can indicate a need to adjust the medication dosage or explore alternative treatments.